Bios Clinical Opportunity Fund, LP - Insider Non-Derivative Transactions at ACTUATE THERAPEUTICS, INC. (ACTU) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 14, 2024, Bios Clinical Opportunity Fund, LP's relationship to ACTUATE THERAPEUTICS, INC. (ACTU) is Director,TenPercentOwner, and currently has 980,433 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ACTU insiders.

Data Source: SEC.
Bios Clinical Opportunity Fund, LP - Insider Non-Derivative Transactions of ACTU Common Stock
Bios Clinical Opportunity Fund, LP - Insider Non-Derivative Transactions at ACTU
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 15, 2024 Sell -- (Common Stock) 2324 8 131248
Aug 15, 2024 Sell -- (Common Stock) 5314 8 300143
Aug 15, 2024 Sell -- (Common Stock) 17361 8 980433